Chauhan H P S, Carpenter Jaswant, Joshi Sapana
School of Chemical Sciences, Devi Ahilya University, Takshashila Campus, Khandwa Road, Indore 452001, India.
School of Chemical Sciences, Devi Ahilya University, Takshashila Campus, Khandwa Road, Indore 452001, India.
Spectrochim Acta A Mol Biomol Spectrosc. 2014 Sep 15;130:230-7. doi: 10.1016/j.saa.2014.03.054. Epub 2014 Apr 13.
The bis(N,N-dimethyldithiocarbamato-S,S')antimony(III) complexes have been obtained by the reaction of chloro bis(N,N-dimethyldithiocarbamato-S,S')antimony(III) with corresponding oxo or thio donor ligands such as sodium benzoate 1, sodium thioglycolate 2, phenol 3, sodium 1-propanethiolate 4, potassium thioacetate 5, sodium salicylate 6, ethane-1,2-dithiolate 7 and disodium oxalate 8. These complexes have been characterized by the physicochemical [melting point, molecular weight determination and elemental analysis (C, H, N, S and Sb)], spectral [UV-Visible, FT-IR, far IR, NMR (1H and 13C)], thermogravimetric (TG & DTA) analysis, ESI-Mass and powder X-ray diffraction studies. Thermogravimetric analysis of the complexes confirmed the final decomposition product as highly pure antimony sulfide (Sb2S3) and powder X-ray diffraction studies show that the complexes are in lower symmetry with monoclinic crystal lattice and nano-ranged particle size (11.51-20.82 nm). The complexes have also been screened against some bacterial and fungal strains for their antibacterial and antifungal activities and compared with standard drugs. These show that the complexes have greater activities against some human pathogenic bacteria and fungi than the activities of standard drugs.
双(N,N - 二甲基二硫代氨基甲酰基 - S,S')锑(III)配合物是通过氯代双(N,N - 二甲基二硫代氨基甲酰基 - S,S')锑(III)与相应的含氧或含硫供体配体反应制得的,这些配体如苯甲酸钠1、巯基乙酸钠2、苯酚3、1 - 丙硫醇钠4、硫代乙酸钾5、水杨酸钠6、乙烷 - 1,2 - 二硫醇盐7和草酸钠8。这些配合物已通过物理化学方法[熔点、分子量测定和元素分析(C、H·、N、S和Sb)]、光谱方法[紫外 - 可见光谱、傅里叶变换红外光谱、远红外光谱、核磁共振(1H和13C)]、热重分析(TG和DTA)、电喷雾质谱和粉末X射线衍射研究进行了表征。配合物的热重分析证实最终分解产物为高纯度硫化锑(Sb2S3),粉末X射线衍射研究表明配合物具有较低的对称性,属于单斜晶格且粒径在纳米范围(11.51 - 20.82 nm)。还对这些配合物针对一些细菌和真菌菌株进行了抗菌和抗真菌活性筛选,并与标准药物进行了比较。结果表明,这些配合物对一些人类致病细菌和真菌的活性比标准药物的活性更强。